Namibia vs Tonga: Amphetamine use disorder death rate by age
Namibia
0 deaths per 100,000 people
in 2021
Tonga
0 deaths per 100,000 people
in 2021
Namibia rank
1st
Tonga rank
1st
Amphetamine use disorder death rate by age over time
- Namibia
- Tonga
How they compare
Namibia currently reports 0 deaths per 100,000 people against 0 deaths per 100,000 people in Tonga, a difference of 0 deaths per 100,000 people.
Across all 22 years both countries report, Tonga has been ahead every year.
Namibia ranks 1st and Tonga ranks 1st of 194 countries.
Head to head by decade
| Decade | Namibia | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 deaths per 100,000 people | 0 deaths per 100,000 people | 0 deaths per 100,000 people | — |
| 2010s | 0 deaths per 100,000 people | 0 deaths per 100,000 people | 0 deaths per 100,000 people | — |
| 2020s | 0 deaths per 100,000 people | 0 deaths per 100,000 people | 0 deaths per 100,000 people | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher amphetamine use disorder death rate by age, Namibia or Tonga?
- Namibia, at 0 deaths per 100,000 people against 0 deaths per 100,000 people in Tonga as of 2021.
- What is the difference in amphetamine use disorder death rate by age between Namibia and Tonga?
- 0 deaths per 100,000 people, with Namibia ahead.
- How many years of comparable data are there for Namibia and Tonga?
- 22 years are reported by both, from 2000 to 2021.
- How do Namibia and Tonga rank globally for amphetamine use disorder death rate by age?
- Namibia ranks 1st and Tonga ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Amphetamine use disorder death rate by age. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from amphetamine use disorders among both sexes aged 0-4 year olds, per 100,000 people.